Funder
National Natural Science Foundation of China
Fundamental Research Funds for the Central Universities
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel quinazolines bearing 1,3,4-thiadiazole-aryl urea derivative as anticancer agents: design, synthesis, molecular docking, DFT and bioactivity evaluations;BMC Chemistry;2024-02-12
2. Angiogenic signaling pathways and anti-angiogenic therapy for cancer;Signal Transduction and Targeted Therapy;2023-05-11
3. Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy;Bioorganic Chemistry;2023-04
4. Design and biological evaluation of 3-substituted quinazoline-2,4(1
H
,3
H
)-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors;Journal of Enzyme Inhibition and Medicinal Chemistry;2023-03-15
5. Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors;Frontiers in Chemistry;2022-04-06